Form 8-K - Current report:
SEC Accession No. 0001140361-21-037501
Filing Date
2021-11-12
Accepted
2021-11-12 06:05:31
Documents
43
Period of Report
2021-11-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10030727_8k.htm   iXBRL 8-K 28851
2 EXHIBIT 99.1 brhc10030727_ex99-1.htm EX-99.1 47941
6 brhc10030727_ex99-1slide31.jpg GRAPHIC 61427
7 brhc10030727_ex99-1slide32.jpg GRAPHIC 340198
8 brhc10030727_ex99-1slide33.jpg GRAPHIC 211615
9 brhc10030727_ex99-1slide34.jpg GRAPHIC 79008
10 brhc10030727_ex99-1slide35.jpg GRAPHIC 126096
11 brhc10030727_ex99-1slide36.jpg GRAPHIC 91596
12 brhc10030727_ex99-1slide37.jpg GRAPHIC 90297
13 brhc10030727_ex99-1slide38.jpg GRAPHIC 117459
14 brhc10030727_ex99-1slide39.jpg GRAPHIC 139156
15 brhc10030727_ex99-1slide40.jpg GRAPHIC 122198
16 brhc10030727_ex99-1slide41.jpg GRAPHIC 126453
17 brhc10030727_ex99-1slide42.jpg GRAPHIC 40180
18 brhc10030727_ex99-1slide43.jpg GRAPHIC 139831
19 brhc10030727_ex99-1slide44.jpg GRAPHIC 99148
20 brhc10030727_ex99-1slide45.jpg GRAPHIC 111576
21 brhc10030727_ex99-1slide46.jpg GRAPHIC 142655
22 brhc10030727_ex99-1slide47.jpg GRAPHIC 132940
23 brhc10030727_ex99-1slide48.jpg GRAPHIC 39942
24 brhc10030727_ex99-1slide49.jpg GRAPHIC 123311
25 brhc10030727_ex99-1slide50.jpg GRAPHIC 40310
26 brhc10030727_ex99-1slide51.jpg GRAPHIC 140451
27 brhc10030727_ex99-1slide52.jpg GRAPHIC 102702
28 brhc10030727_ex99-1slide53.jpg GRAPHIC 41118
29 brhc10030727_ex99-1slide54.jpg GRAPHIC 116391
30 brhc10030727_ex99-1slide55.jpg GRAPHIC 125198
31 brhc10030727_ex99-1slide56.jpg GRAPHIC 122841
32 brhc10030727_ex99-1slide57.jpg GRAPHIC 126636
33 brhc10030727_ex99-1slide58.jpg GRAPHIC 136990
34 brhc10030727_ex99-1slide59.jpg GRAPHIC 129813
35 brhc10030727_ex99-1slide60.jpg GRAPHIC 121715
  Complete submission text file 0001140361-21-037501.txt   5101819

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btx-20211111.xsd EX-101.SCH 3929
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE btx-20211111_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btx-20211111_pre.xml EX-101.PRE 16047
36 EXTRACTED XBRL INSTANCE DOCUMENT brhc10030727_8k_htm.xml XML 4246
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 211398916
SIC: 2834 Pharmaceutical Preparations